(Q71993108)
Statements
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group (English)
T Lenderink
M L Simoons
G A Van Es
F Van de Werf
M Verstraete
1 September 1995